Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

Table 5

Prognostic factors by univariate analysis and multivariate analysis.

Prognostic factors	Univariate analysis	Multivariate analysis
		Relative risk (95% CI)
Male	0.55	—	—
Age (<40)	0.15	—	—
PS (0)	0.012	—	0.54
Number of involved organs (<3)	0.013	0.31 (0.15–0.65)	0.0019
Head and neck	0.28	—	—
Intra-abdomen	0.25	—	—
Retroperitoneum	0.17	—	—
Lung	0.34	—	—
Liver	0.30	—	—
Bone	0.60	—	—
Lymph node	0.84	—	—
No bulky mass (<5 cm)	0.009	0.27 (0.12–0.60)	0.0013
Pretreatment	0.73	—	—
Normal, N/l	0.44	—	—
Normal Hb level (≧11.6 g/dl)	0.18	—	—
Normal LDH level (<222 mg/dl)	0.61	—	—
Normal ALP level (<322 IU/l)	0.12	—	—
Normal CRP level (<0.14 mg/dl)	0.020	0.43 (0.20–0.93)	0.032